Position in ABBV
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$32,075,040
+$4,353,330 QoQ
Shares Held
127,464
+0.0% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
3.13%
of 13F equity value
Holder Rank
#467
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Rodgers Brothers Inc. holds $137,046,562 across 11 Drug Manufacturers - General names. ABBV ranks #2 (23.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
55,538 | $66,613,948 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
127,464 | $32,075,040 | |
| 3 | JNJ |
Johnson & Johnson
|
63,682 | $16,173,317 | |
| 4 | MRK |
Merck & Co., Inc.
|
102,689 | $13,195,536 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
79,062 | $4,555,552 | |
| 6 | NVO |
Novo Nordisk A S
|
42,450 | $2,035,053 | |
| 7 | PFE |
Pfizer Inc
|
33,453 | $805,548 | |
| 8 | AMGN |
Amgen Inc
|
1,897 | $686,941 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $32,075,040 | 127,464 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $27,721,710 | 127,462 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $29,011,832 | 126,972 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $29,893,203 | 129,106 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $24,400,862 | 131,456 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $27,682,620 | 132,124 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $23,553,957 | 132,549 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $26,309,075 | 133,224 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $22,912,499 | 133,585 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $24,431,082 | 134,163 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $20,044,904 | 129,347 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $20,007,131 | 134,222 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $17,373,029 | 128,947 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $19,619,721 | 123,108 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $19,749,065 | 122,202 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $16,440,053 | 122,495 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $18,835,923 | 122,982 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $20,030,149 | 123,559 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $16,874,360 | 124,626 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $13,446,103 | 124,651 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $15,461,642 | 137,266 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $14,974,726 | 138,373 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $14,523,432 | 135,543 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $11,429,356 | 130,487 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $12,825,646 | 130,634 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $10,042,375 | 131,807 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||